Evofem stockholders approve reverse stock split (1:500–1,500) and elect four directors

Evofem Biosciences, Inc.

Stockholders approved reverse stock split of Common Stock at ratio between 1:500 and 1:1,500, with Board discretion to implement by Nov 2026.
Four directors elected to Class I/II: Kamdar, Rutherford, Rarick, O'Brien; each received over 167M votes for.
Say-on-pay and 2025 Equity Incentive Plan both approved; BPM LLP ratified as auditor.
Series E-1 and G-1 preferred stockholders unanimously voted for reverse split.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Evofem Biosciences, Inc.: Stockholders approved a resolution to amend the Certificate of Incorporation to effect a one-time reverse stock split of Common Stock at a ratio between 1-for-500 and 1-for-1,500, at any time before November 26, 2026 (effective 2026-11-26).

Change: charter amendment
Effective: 2026-11-26

Exact text from the filing

At the Annual Meeting, the Company’s stockholders approved a resolution as previously approved by the Company’s Board of Directors (“Board”) to amend the Company’s existing Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”) to effect a one-time reverse stock split of the Company’s Common Stock, to effectuate a reverse stock split of the outstanding shares of the Company’s Common Stock by a ratio of not less than 1-for-500 and not more than 1-for-1,500 at any time before November 26, 2026.

View on SEC.gov

269 governance changes filed in the last 30 days. Browse all governance changes →

Evofem Biosciences, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-25-025172

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.